Exact Mass: 450.1937
Exact Mass Matches: 450.1937
Found 39 metabolites which its exact mass value is equals to given mass value 450.1937,
within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error
8.0E-6 dalton.
Acotiamide
N-{2-[bis(propan-2-yl)amino]ethyl}-2-{[hydroxy(2-hydroxy-4,5-dimethoxyphenyl)methylidene]amino}-1,3-thiazole-4-carboximidate
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D005765 - Gastrointestinal Agents D004791 - Enzyme Inhibitors
Phe Gly Met Pro
(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid
Phe Gly Pro Met
(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-phenylpropanamido]acetyl}pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid
Phe Met Gly Pro
(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]acetyl}pyrrolidine-2-carboxylic acid
Phe Met Pro Gly
2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}acetic acid
Phe Pro Gly Met
(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)-4-(methylsulfanyl)butanoic acid
Phe Pro Met Gly
2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]acetic acid
Gly Phe Met Pro
(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid
Gly Phe Pro Met
(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid
Gly Met Phe Pro
(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid
Gly Met Pro Phe
(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid
Gly Pro Phe Met
(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid
Gly Pro Met Phe
(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid
Met Phe Gly Pro
(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]acetyl}pyrrolidine-2-carboxylic acid
Met Phe Pro Gly
2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}acetic acid
Met Gly Phe Pro
(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid
Met Gly Pro Phe
(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetyl}pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid
Met Pro Phe Gly
2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanamido]acetic acid
Met Pro Gly Phe
(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-phenylpropanoic acid
Pro Phe Gly Met
(2S)-4-(methylsulfanyl)-2-{2-[(2S)-3-phenyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}butanoic acid
Pro Phe Met Gly
2-[(2S)-4-(methylsulfanyl)-2-[(2S)-3-phenyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]acetic acid
Pro Gly Phe Met
(2S)-4-(methylsulfanyl)-2-[(2S)-3-phenyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]butanoic acid
Pro Gly Met Phe
(2S)-2-[(2S)-4-(methylsulfanyl)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]-3-phenylpropanoic acid
Pro Met Phe Gly
2-[(2S)-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-phenylpropanamido]acetic acid
Pro Met Gly Phe
(2S)-2-{2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}-3-phenylpropanoic acid
N-[(2S,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2S,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylpyrazine-2-carboxamide
N-[(2R,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylpyrazine-2-carboxamide
N-[(2R,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylpyrazine-2-carboxamide
N-[(2R,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylpyrazine-2-carboxamide
N-[(2S,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2S,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-N-propyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-N-propyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[(2R,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2S,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2S,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2S,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2S,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-N-propyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-methylsulfonyl-N-propyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-methylsulfonyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
Acotiamide
Acotiamide
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D005765 - Gastrointestinal Agents D004791 - Enzyme Inhibitors
